Advanced search
Publication Cover
Infection and Drug Resistance Volume 11, 2018 - Issue
Submit an article Journal homepage
129
Views
37
CrossRef citations to date
0
Altmetric
Original Research

Inhibitory effects of fluoroquinolone antibiotics on Babesia divergens and Babesia microti, blood parasites of veterinary and zoonotic importance

Mohamed Abdo Rizk1 National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-Cho, Obihiro, Hokkaido, Japan;2 Department of Internal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt
,
Mahmoud AbouLaila3 Department of Parasitology and Pathology, Faculty of Veterinary Medicine, Damanhour University, Damanhour, ElBehera, Egypt
,
Shimaa Abd El-Salam El-Sayed1 National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-Cho, Obihiro, Hokkaido, Japan;4 Department of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt
,
Azirwan Guswanto1 National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-Cho, Obihiro, Hokkaido, Japan;5 Veterinary Services Section, Disease Investigation Center, Subang, West Java, Indonesia
,
Naoaki Yokoyama1 National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-Cho, Obihiro, Hokkaido, Japan
&
Ikuo Igarashi1 National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-Cho, Obihiro, Hokkaido, JapanCorrespondence[email protected]
Pages 1605-1615 | Published online: 28 Sep 2018

References

  • Uilenberg G. Babesia – a historical overview. Vet Parasitol. 2006;31:3–10.
  • Homer JM, Aguilar-Delfin I, Telford SR, et al. Babesiosis. Clin Microbiol Rev. 2000;13:451–469.
  • Zintl A, Mulcahy G, Skerrett HE, et al. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev. 2003;16:622–636.
  • Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, et al. Current advances in detection and treatment of babesiosis. Curr Med Chem. 2012;19:1504–1518.
  • Drlica K. Mechanism of fluoroquinolone action. Curr Opin Microbiol. 1999;2:504–508.
  • McFadden GI, Roos DS. Apicomplexan plastids as drug targets. Trends Microbiol. 1999;7:328–333.
  • Morrison DA. Evolution of the Apicomplexa. Where are we now? Trends Parasitol. 2009;25:375–382.
  • García-Estrada C, Prada CF, Fernández-Rubio C, et al. DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery. Proc Biol Sci. 2010;277:1777–1787.
  • Rizk MA, El-Sayed SA, AbouLaila M, et al. Large-scale drug screening against Babesia divergens parasite using a fluorescence-based high-throughput screening assay. Vet Parasitol. 2016;227:93–97.
  • Rizk MA, El-Sayed SAE, AbouLaila M, et al. Performance and consistency of a fluorescence-based high-throughput screening assay for use in Babesia drug screening in mice. Sci Rep. 2017;7:12774.
  • Salama AA, AbouLaila M, Terkawi MA, et al. Inhibitory effect of allicin on the growth of Babesia and Theileria equi parasites. Parasitol Res. 2014;113:275–283.
  • Suleman N, Kalhapure RS, Mocktar C, et al. Silver salts of carboxylic acid terminated generation 1 poly (propyl ether imine) (PETIM) dendron and dendrimers as antimicrobial agents against S. aureus and MRSA. RSC Advances. 2015;5:34967–34978.
  • Hamzah J, Skinner-Adams T, Davis TME. In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone. Acta Trop. 2000;74:39–42.
  • Watt G, Shanks GD, Einstein MD, et al. Ciprofloxacin treatment of drug-resistant falciparum malaria. J Infect Dis. 1991;164:602–604.
  • Mahmoudi N, Ciceron L, Franetich JF, et al. In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp. Antimicrob Agents Chemother. 2003;47:2636–2639.
  • Rizk MA, El-Sayed SA, Terkawi MA, et al. Optimization of a fluorescence-based assay for large-scale drug screening against Babesia and Theileria parasites. PLoS One. 2015;10:e0125276.
  • Rizk MA, El-Sayed SAE, AbouLaila M, et al. Evaluation of the inhibitory effect of N-acetyl-L-cysteine on Babesia and Theileria parasites. Exp Parasitol. 2017;179:43–48.
  • AbouLaila M, Munkhjargal T, Sivakumar T, et al. Apicoplast-targeting antibacterials inhibit the growth of Babesia parasites. Antimicrob Agents Chemother. 2012;56:3196–3206.
  • Wise R, Lockley R, Dent J, et al. Pharmacokinetics and tissue penetration of enoxacin. Antimicrob Agents Chemother. 1984;26:17–19.
  • Rafalsky V, Andreeva I, Rjabkova E, et al. Quinolones for uncomplicated acute cystitis in women. Cochrane Database Syst Rev. 2006;3:CD003597.
  • Wise R, Lister D, McNulty CA, et al. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin. Infection. 1986;14:196–202.
  • Marley SE, Eberhard ML, Steurer FJ, et al. Evaluation of selected antiprotozoal drugs in the Babesia microti hamster model. Antimicrob Agents Chemother. 1997;41:91–94.
  • Tuvshintulga B, AbouLaila M, Davaasuren B, et al. Clofazimine inhibits the growth of Babesia and Theileria parasites in vitro and in vivo. Antimicrob Agents Chemother. 2016;60:2739–2746.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.